Skip to main content

Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood–Brain Barrier

Journal of Molecular Neuroscience volume 49, pages 270–276 (2013)Cite this article

Abstract

Alzheimer’s disease (AD) is a neurodegenerative process characterized, in part, by the accumulation of beta-amyloid proteins (Aβ) in the brain. Evidence now suggests that the excessive Aβ accumulation is the result of impaired clearance from the brain. Recent studies have indicated that retinoid X receptor (RXR) activation stimulates the metabolic clearance of Aβ and rapidly reverses Aβ-induced behavioral deficits, doing so in an apoE-dependent manner. Previously, we reported that soluble apoE (i.e., not bound to Aβ) facilitated Aβ transit across the blood–brain barrier (BBB). As Aβ clearance from the brain involves both metabolic and BBB-mediated processes, the current studies investigated the impact of RXR stimulation on Aβ clearance across the BBB. Treatment with RXR agonists increased Aβ clearance across the BBB both in vitro and in vivo. Moreover, this processes appeared to involve apoE as RXR agonism did not stimulate Aβ BBB clearance when apoE was absent. Thus, RXR activation could mitigate Aβ brain burden by promoting both the metabolic and BBB clearance of Aβ, offering a novel approach to the treatment of AD.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  • Bachmeier C, Mullan M, Paris D (2010) Characterization and use of human brain microvascular endothelial cells to examine beta-amyloid exchange in the blood–brain barrier. Cytotechnology 62:519–529

    PubMed  CAS  Article  Google Scholar 

  • Bachmeier C, Paris D, Beaulieu-Abdelahad D, Mouzon B, Mullan M, Crawford F (2012) A multifaceted role for apoe in the clearance of beta-amyloid across the blood–brain barrier. Neurodegener Dis. doi:10.1159/000337231

  • Bachmeier CJ, Beaulieu-Abdelahad D, Mullan MJ, Paris D (2011) Epitope-dependent effects of beta-amyloid antibodies on beta-amyloid clearance in an in vitro model of the blood–brain barrier. Microcirculation 18:373–379

    PubMed  CAS  Article  Google Scholar 

  • Bu G (2009) Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333–344

    PubMed  CAS  Article  Google Scholar 

  • Burgess JW, Marcel YL (2001) Dynamic and stable pools of apoE differ functionally at the hepg2 cell surface. J Lipid Res 42:1413–1420

    PubMed  CAS  Google Scholar 

  • Camacho IE, Serneels L, Spittaels K, Merchiers P, Dominguez D, De Strooper B (2004) Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide. J Neurosci 24:10908–10917

    PubMed  CAS  Article  Google Scholar 

  • Castellano JM, Kim J, Stewart FR et al (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3:89ra57

    Google Scholar 

  • Chan GN, Hoque MT, Cummins CL, Bendayan R (2011) Regulation of p-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells. J Neurochem 118:163–175

    PubMed  CAS  Article  Google Scholar 

  • Cirrito JR, Deane R, Fagan AM et al (2005) P-glycoprotein deficiency at the blood–brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285–3290

    PubMed  CAS  Article  Google Scholar 

  • Cramer PE, Cirrito JR, Wesson DW et al (2012) Apoe-directed therapeutics rapidly clear beta-amyloid and reverse deficits in ad mouse models. Science 335:1503–1506

    PubMed  CAS  Article  Google Scholar 

  • Dawson MI, Xia Z (2012) The retinoid x receptors and their ligands. Biochim Biophys Acta 1821:21–56

    PubMed  CAS  Article  Google Scholar 

  • Deane R, Sagare A, Hamm K et al (2008) Apoe isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118:4002–4013

    PubMed  CAS  Article  Google Scholar 

  • Do TM, Noel-Hudson MS, Ribes S et al (2012) Abcg2- and abcg4-mediated efflux of amyloid-beta peptide 1-40 at the mouse blood–brain barrier. J Alzheimers Dis 30:155–166

    PubMed  CAS  Google Scholar 

  • Fitz NF, Cronican A, Pham T et al (2010) Liver x receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in app 23 mice. J Neurosci 30:6862–6872

    PubMed  CAS  Article  Google Scholar 

  • Gauthier A, Vassiliou G, Benoist F, McPherson R (2003) Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma. J Biol Chem 278:11945–11953

    PubMed  CAS  Article  Google Scholar 

  • Hessel S, Lampen A (2010) All-trans retinoic acid enhances the transport of phase ii metabolites of benzo[a]pyrene by inducing the breast cancer resistance protein expression in caco-2 cells. Toxicol Lett 197:151–155

    PubMed  CAS  Article  Google Scholar 

  • Jiang Q, Lee CY, Mandrekar S et al (2008) Apoe promotes the proteolytic degradation of abeta. Neuron 58:681–693

    PubMed  CAS  Article  Google Scholar 

  • Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63:287–303

    PubMed  CAS  Article  Google Scholar 

  • Kockx M, Guo DL, Huby T et al (2007) Secretion of apolipoprotein e from macrophages occurs via a protein kinase A and calcium-dependent pathway along the microtubule network. Circ Res 101:607–616

    PubMed  CAS  Article  Google Scholar 

  • Kockx M, Jessup W, Kritharides L (2008) Regulation of endogenous apolipoprotein E secretion by macrophages. Arterioscler Thromb Vasc Biol 28:1060–1067

    PubMed  CAS  Article  Google Scholar 

  • Krohn M, Lange C, Hofrichter J et al (2011) Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein abcc1 in mice. J Clin Invest 121:3924–3931

    PubMed  CAS  Article  Google Scholar 

  • Kuhnke D, Jedlitschky G, Grube M et al (2007) Mdr1-p-glycoprotein (abcb1) mediates transport of Alzheimer’s amyloid-beta peptides–implications for the mechanisms of abeta clearance at the blood–brain barrier. Brain Pathol 17:347–353

    PubMed  CAS  Article  Google Scholar 

  • LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 8:499–509

    PubMed  CAS  Article  Google Scholar 

  • Lefebvre P, Benomar Y, Staels B (2010) Retinoid x receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab 21:676–683

    PubMed  CAS  Article  Google Scholar 

  • Liang Y, Lin S, Beyer TP et al (2004) A liver x receptor and retinoid x receptor heterodimer mediates apolipoprotein e expression, secretion and cholesterol homeostasis in astrocytes. J Neurochem 88:623–634

    PubMed  CAS  Article  Google Scholar 

  • Lucas M, Mazzone T (1996) Cell surface proteoglycans modulate net synthesis and secretion of macrophage apolipoprotein E. J Biol Chem 271:13454–13460

    PubMed  CAS  Article  Google Scholar 

  • Mawuenyega KG, Sigurdson W, Ovod V et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330:1774

    PubMed  CAS  Article  Google Scholar 

  • McLean CA, Cherny RA, Fraser FW et al (1999) Soluble pool of abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 46:860–866

    PubMed  CAS  Article  Google Scholar 

  • Mehta PD (2007) Amyloid beta protein as a marker or risk factor of Alzheimer’s disease. Curr Alzheimer Res 4:359–363

    PubMed  CAS  Article  Google Scholar 

  • Nordberg A (2008) Amyloid imaging in Alzheimer’s disease. Neuropsychologia 46:1636–1641

    PubMed  Article  Google Scholar 

  • Paris D, Bachmeier C, Patel N et al (2011) Selective antihypertensive dihydropyridines lower abeta accumulation by targeting both the production and the clearance of abeta across the blood–brain barrier. Mol Med 17:149–162

    PubMed  CAS  Article  Google Scholar 

  • Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89:4471–4475

    PubMed  CAS  Article  Google Scholar 

  • Podlisny MB, Ostaszewski BL, Squazzo SL et al (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 270:9564–9570

    PubMed  CAS  Article  Google Scholar 

  • Podlisny MB, Walsh DM, Amarante P et al (1998) Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry 37:3602–3611

    PubMed  CAS  Article  Google Scholar 

  • Shibata M, Yamada S, Kumar SR et al (2000) Clearance of Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood–brain barrier. J Clin Invest 106:1489–1499

    PubMed  CAS  Article  Google Scholar 

  • Suon S, Zhao J, Villarreal SA et al (2010) Systemic treatment with liver x receptor agonists raises apolipoprotein E, cholesterol, and amyloid-beta peptides in the cerebral spinal fluid of rats. Mol Neurodegener 5:44

    PubMed  Article  Google Scholar 

  • Tai LM, Loughlin AJ, Male DK, Romero IA (2009) P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta. J Cereb Blood Flow Metab 29:1079–1083

    PubMed  CAS  Article  Google Scholar 

  • Tao H, Aakula S, Abumrad NN, Hajri T (2010) Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor. Am J Physiol Endocrinol Metab 298:E68–E79

    PubMed  CAS  Article  Google Scholar 

  • Tsukuda K, Mogi M, Iwanami J et al (2009) Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 54:782–787

    PubMed  CAS  Article  Google Scholar 

  • Vogelgesang S, Cascorbi I, Schroeder E et al (2002) Deposition of Alzheimer’s beta-amyloid is inversely correlated with p-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12:535–541

    PubMed  CAS  Article  Google Scholar 

  • Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102

    PubMed  CAS  Article  Google Scholar 

  • Wells JM, Amaratunga A, McKenna DC, Abraham CR, Fine RE (1995) Amyloid β-protein precursor and apolipoprotein e production in cultured cerebral endothelial cells isolated from brains of patients with neurodegenerative disorders at autopsy. Amyloid 2:229–233

    CAS  Article  Google Scholar 

  • Yue L, Mazzone T (2009) Peroxisome proliferator-activated receptor gamma stimulation of adipocyte apoe gene transcription mediated by the liver receptor x pathway. J Biol Chem 284:10453–10461

    PubMed  CAS  Article  Google Scholar 

  • Zelcer N, Khanlou N, Clare R et al (2007) Attenuation of neuroinflammation and Alzheimer’s disease pathology by liver x receptors. Proc Natl Acad Sci USA 104:10601–10606

    PubMed  CAS  Article  Google Scholar 

  • Zhong N, Weisgraber KH (2009) Understanding the basis for the association of apoe4 with Alzheimer’s disease: opening the door for therapeutic approaches. Curr Alzheimer Res 6:415–418

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. The Roskamp Institute, 2040 Whitfield Avenue, Sarasota, FL, 34243, USA

    Corbin Bachmeier, David Beaulieu-Abdelahad, Fiona Crawford, Michael Mullan & Daniel Paris

Authors
  1. Corbin Bachmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Beaulieu-Abdelahad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fiona Crawford
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Mullan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Paris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Corbin Bachmeier.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bachmeier, C., Beaulieu-Abdelahad, D., Crawford, F. et al. Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood–Brain Barrier. J Mol Neurosci 49, 270–276 (2013). https://doi.org/10.1007/s12031-012-9866-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-012-9866-6

Keywords

  • Alzheimer’s disease
  • Amyloid
  • Retinoid X receptor
  • Apolipoprotein E
  • Blood–brain barrier